{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T07:10:20Z","timestamp":1761808220749,"version":"build-2065373602"},"reference-count":43,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cardiology Clinics"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1016\/j.ccl.2018.08.002","type":"journal-article","created":{"date-parts":[[2018,9,26]],"date-time":"2018-09-26T15:02:39Z","timestamp":1537974159000},"page":"27-33","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Cardiac Magnetic Resonance for Diagnosis and Risk Stratification"],"prefix":"10.1016","volume":"37","author":[{"given":"Abdallah","family":"Sanaani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anthon","family":"Fuisz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"25","key":"10.1016\/j.ccl.2018.08.002_bib1","doi-asserted-by":"crossref","first-page":"e212","DOI":"10.1016\/j.jacc.2011.06.011","article-title":"2011 ACCF\/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy","volume":"58","author":"Gersh","year":"2011","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"39","key":"10.1016\/j.ccl.2018.08.002_bib2","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.1093\/eurheartj\/ehu284","article-title":"2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy","volume":"35","author":"Elliott","year":"2014","journal-title":"Eur Heart J"},{"issue":"1","key":"10.1016\/j.ccl.2018.08.002_bib3","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/1532-429X-15-35","article-title":"Standardized image interpretation and post processing in cardiovascular magnetic resonance: society for cardiovascular magnetic resonance (SCMR) board of trustees task force on standardized post processing","volume":"15","author":"Schulz-Menger","year":"2013","journal-title":"J\u00a0Cardiovasc Magn Reson"},{"issue":"855","key":"10.1016\/j.ccl.2018.08.002_bib4","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1259\/bjr.72.855.10396215","article-title":"A\u00a0comparison of MRI and echocardiography in hypertrophic cardiomyopathy","volume":"72","author":"Devlin","year":"1999","journal-title":"Br J Radiol"},{"issue":"4","key":"10.1016\/j.ccl.2018.08.002_bib5","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.amjcard.2016.11.010","article-title":"Comparison of maximal wall thickness in hypertrophic cardiomyopathy differs between magnetic resonance imaging and transthoracic echocardiography","volume":"119","author":"Bois","year":"2017","journal-title":"Am J Cardiol"},{"issue":"6","key":"10.1016\/j.ccl.2018.08.002_bib6","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1007\/s10554-016-0858-4","article-title":"Left ventricular wall thickness in patients with hypertrophic cardiomyopathy: a comparison between cardiac magnetic resonance imaging and echocardiography","volume":"32","author":"Corona-Villalobos","year":"2016","journal-title":"Int J Cardiovasc Imaging"},{"issue":"8","key":"10.1016\/j.ccl.2018.08.002_bib7","doi-asserted-by":"crossref","first-page":"e006309","DOI":"10.1161\/CIRCIMAGING.117.006309","article-title":"Discrepant measurements of maximal left ventricular wall thickness between cardiac magnetic resonance imaging and echocardiography in patients with hypertrophic cardiomyopathyclinical perspective","volume":"10","author":"Hindieh","year":"2017","journal-title":"Circ Cardiovasc Imaging"},{"issue":"9","key":"10.1016\/j.ccl.2018.08.002_bib8","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1016\/j.amjcard.2017.01.021","article-title":"Usefulness of cardiac magnetic resonance imaging to measure left ventricular wall thickness for determining risk scores for sudden cardiac death in patients with hypertrophic cardiomyopathy","volume":"119","author":"Webb","year":"2017","journal-title":"Am J Cardiol"},{"year":"2008","series-title":"Assessment and significance of left ventricular mass by cardiovascular magnetic resonance in hypertrophic cardiomyopathy","author":"Olivotto","key":"10.1016\/j.ccl.2018.08.002_bib9"},{"issue":"10","key":"10.1016\/j.ccl.2018.08.002_bib10","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1253\/jcj.65.915","article-title":"Hypertrophic cardiomyopathy with midventricular obstruction and apical aneurysm: a case report","volume":"65","author":"Harada","year":"2001","journal-title":"Jpn Circ J"},{"issue":"1","key":"10.1016\/j.ccl.2018.08.002_bib11","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1136\/heart.83.1.e1","article-title":"Diagnosis of apical hypertrophic cardiomyopathy using magnetic resonance imaging","volume":"83","author":"Ibrahim","year":"2000","journal-title":"Heart"},{"issue":"6","key":"10.1016\/j.ccl.2018.08.002_bib12","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1136\/hrt.2003.014969","article-title":"Detection of apical hypertrophic cardiomyopathy by cardiovascular magnetic resonance in patients with non-diagnostic echocardiography","volume":"90","author":"Moon","year":"2004","journal-title":"Heart"},{"issue":"8","key":"10.1016\/j.ccl.2018.08.002_bib13","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/j.amjcard.2007.05.061","article-title":"Right ventricular involvement in hypertrophic cardiomyopathy","volume":"100","author":"Maron","year":"2007","journal-title":"Am J Cardiol"},{"issue":"7","key":"10.1016\/j.ccl.2018.08.002_bib14","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/j.jacc.2004.12.067","article-title":"The prognostic importance of left ventricular outflow obstruction in hypertrophic cardiomyopathy varies in relation to the severity of symptoms","volume":"45","author":"Autore","year":"2005","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"5","key":"10.1016\/j.ccl.2018.08.002_bib15","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.amjcard.2007.10.032","article-title":"Significance of papillary muscle abnormalities identified by cardiovascular magnetic resonance in hypertrophic cardiomyopathy","volume":"101","author":"Harrigan","year":"2008","journal-title":"Am J Cardiol"},{"issue":"3","key":"10.1016\/j.ccl.2018.08.002_bib16","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1161\/01.CIR.84.3.1188","article-title":"Anomalous insertion of papillary muscle directly into anterior mitral leaflet in hypertrophic cardiomyopathy. Significance in producing left ventricular outflow obstruction","volume":"84","author":"Klues","year":"1991","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.ccl.2018.08.002_bib17","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/S0003-4975(96)01085-5","article-title":"Anomalous papillary muscle as a cause of left ventricular outflow tract obstruction in an adult","volume":"63","author":"Kon","year":"1997","journal-title":"Ann Thorac Surg"},{"issue":"1","key":"10.1016\/j.ccl.2018.08.002_bib18","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1161\/CIRCULATIONAHA.110.985812","article-title":"Mitral Valve abnormalities identified by cardiovascular magnetic resonance represent a primary phenotypic expression of hypertrophic cardiomyopathy","volume":"124","author":"Maron","year":"2011","journal-title":"Circulation"},{"issue":"7","key":"10.1016\/j.ccl.2018.08.002_bib19","doi-asserted-by":"crossref","first-page":"e003132","DOI":"10.1161\/CIRCIMAGING.115.003132","article-title":"Left ventricular outflow tract obstruction in hypertrophic cardiomyopathy patients without severe septal hypertrophy: implications of mitral valve and papillary muscle abnormalities assessed using cardiac magnetic resonance and echocardiography","volume":"8","author":"Patel","year":"2015","journal-title":"Circ Cardiovasc Imaging"},{"issue":"11","key":"10.1016\/j.ccl.2018.08.002_bib20","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1016\/j.jacc.2014.12.047","article-title":"Discordance between echocardiography and MRI in the assessment of mitral regurgitation severity","volume":"65","author":"Uretsky","year":"2015","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"13","key":"10.1016\/j.ccl.2018.08.002_bib21","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1161\/CIRCULATIONAHA.117.029332","article-title":"Prognostic implications of magnetic resonance-derived quantification in asymptomatic patients with organic mitral\u00a0regurgitation: comparison with Doppler echocardiography-derived integrative approach","volume":"137","author":"Penicka","year":"2018","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.ccl.2018.08.002_bib22","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.acvd.2011.12.006","article-title":"Patterns of\u00a0myocardial late enhancement: typical and atypical features","volume":"105","author":"Vermes","year":"2012","journal-title":"Arch Cardiovasc Dis"},{"issue":"7","key":"10.1016\/j.ccl.2018.08.002_bib23","doi-asserted-by":"crossref","first-page":"585","DOI":"10.4330\/wjc.v6.i7.585","article-title":"Distribution of late gadolinium enhancement in various types of cardiomyopathies: significance in differential diagnosis, clinical features and prognosis","volume":"6","author":"Satoh","year":"2014","journal-title":"World J Cardiol"},{"issue":"2","key":"10.1016\/j.ccl.2018.08.002_bib24","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.mri.2003.08.009","article-title":"Delayed contrast enhancement of MRI in hypertrophic cardiomyopathy","volume":"22","author":"Teraoka","year":"2004","journal-title":"Magn Reson Imaging"},{"issue":"17","key":"10.1016\/j.ccl.2018.08.002_bib25","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1136\/heartjnl-2015-307682","article-title":"Myocardial fibrosis on cardiac magnetic resonance and cardiac outcomes in hypertrophic cardiomyopathy: a meta-analysis","volume":"101","author":"Briasoulis","year":"2015","journal-title":"Heart"},{"key":"10.1016\/j.ccl.2018.08.002_bib26","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1161\/CIRCHEARTFAILURE.108.768119","article-title":"Clinical profile and significance of delayed enhancement in\u00a0hypertrophic cardiomyopathy","volume":"1","author":"Hanna","year":"2008","journal-title":"Circ Heart Fail"},{"issue":"1","key":"10.1016\/j.ccl.2018.08.002_bib27","first-page":"49","article-title":"The value of cardiac magnetic resonance and distribution of late gadolinium enhancement for risk stratification of sudden cardiac death in patients with hypertrophic cardiomyopathy","volume":"68","author":"Klopotowski","year":"2016","journal-title":"J\u00a0Cardiol"},{"issue":"11","key":"10.1016\/j.ccl.2018.08.002_bib28","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/j.jacc.2010.05.010","article-title":"Prognostic significance of myocardial fibrosis in hypertrophic cardiomyopathy","volume":"56","author":"O\u2019Hanlon","year":"2010","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"6","key":"10.1016\/j.ccl.2018.08.002_bib29","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1161\/CIRCULATIONAHA.113.007094","article-title":"Prognostic value of quantitative contrast-enhanced cardiovascular magnetic resonance for the evaluation of sudden death risk in patients with hypertrophic cardiomyopathy","volume":"130","author":"Chan","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.ccl.2018.08.002_bib30","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1532-429X-12-30","article-title":"Extent of late gadolinium enhancement detected by cardiovascular magnetic resonance correlates with the inducibility of ventricular tachyarrhythmia in hypertrophic cardiomyopathy","volume":"12","author":"Fluechter","year":"2010","journal-title":"J\u00a0Cardiovasc Magn Reson"},{"issue":"5","key":"10.1016\/j.ccl.2018.08.002_bib31","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.hlc.2008.03.080","article-title":"Myocardial scar detected by contrast-enhanced cardiac magnetic resonance imaging is associated with ventricular tachycardia in hypertrophic cardiomyopathy patients","volume":"17","author":"Suk","year":"2008","journal-title":"Heart Lung Circ"},{"issue":"12","key":"10.1016\/j.ccl.2018.08.002_bib32","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1016\/j.jcmg.2016.02.031","article-title":"Prognostic value of LGE-CMR in HCM: a meta-analysis","volume":"9","author":"Weng","year":"2016","journal-title":"JACC Cardiovasc Imaging"},{"issue":"1","key":"10.1016\/j.ccl.2018.08.002_bib33","doi-asserted-by":"crossref","first-page":"6336","DOI":"10.1038\/s41598-017-06533-0","article-title":"Incremental benefit of late gadolinium cardiac magnetic resonance imaging for risk stratification in patients with hypertrophic cardiomyopathy","volume":"7","author":"Doesch","year":"2017","journal-title":"Sci Rep"},{"issue":"6","key":"10.1016\/j.ccl.2018.08.002_bib34","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1161\/CIRCIMAGING.112.976738","article-title":"Myocardial tissue characterization using magnetic resonance noncontrast T1 mapping in hypertrophic and dilated cardiomyopathy","volume":"5","author":"Dass","year":"2012","journal-title":"Circ Cardiovasc Imaging"},{"issue":"1","key":"10.1016\/j.ccl.2018.08.002_bib35","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1093\/ehjci\/jeu182","article-title":"Histological validation of cardiac magnetic resonance analysis of regional and diffuse interstitial myocardial fibrosis","volume":"16","author":"Iles","year":"2015","journal-title":"Eur Heart J Cardiovasc Imaging"},{"issue":"6","key":"10.1016\/j.ccl.2018.08.002_bib36","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/j.mri.2015.04.001","article-title":"Native T1-mapping for non-contrast assessment of myocardial fibrosis in patients with hypertrophic cardiomyopathy - comparison with late enhancement quantification","volume":"33","author":"Ma\u0142ek","year":"2015","journal-title":"Magn Reson Imaging"},{"issue":"12","key":"10.1016\/j.ccl.2018.08.002_bib37","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.115.003285","article-title":"T1 mapping in discrimination of hypertrophic phenotypes: hypertensive heart disease and hypertrophic cardiomyopathy: findings from the international T1 multicenter cardiovascular magnetic resonance study","volume":"8","author":"Hinojar","year":"2015","journal-title":"Circ Cardiovasc Imaging"},{"issue":"4","key":"10.1016\/j.ccl.2018.08.002_bib38","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.jcmg.2012.08.019","article-title":"Native T1 mapping in differentiation of normal myocardium from diffuse disease in hypertrophic and dilated\u00a0cardiomyopathy","volume":"6","author":"Puntmann","year":"2013","journal-title":"JACC Cardiovasc Imaging"},{"issue":"1","key":"10.1016\/j.ccl.2018.08.002_bib39","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.jcmg.2015.12.001","article-title":"T1-Mapping and outcome in nonischemic cardiomyopathy","volume":"9","author":"Puntmann","year":"2016","journal-title":"JACC Cardiovasc Imaging"},{"issue":"7","key":"10.1016\/j.ccl.2018.08.002_bib40","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/j.jacc.2017.12.020","article-title":"Native T1 and ECV of noninfarcted myocardium and outcome in patients with coronary artery disease","volume":"71","author":"Puntmann","year":"2018","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"5","key":"10.1016\/j.ccl.2018.08.002_bib41","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.crad.2014.12.018","article-title":"Rest perfusion abnormalities in hypertrophic cardiomyopathy: correlation with myocardial fibrosis and risk factors for\u00a0sudden cardiac death","volume":"70","author":"Chiribiri","year":"2015","journal-title":"Clin Radiol"},{"key":"10.1016\/j.ccl.2018.08.002_bib42","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s12968-014-0049-1","article-title":"Coronary microvascular ischemia in hypertrophic cardiomyopathy - a pixel-wise quantitative cardiovascular magnetic resonance perfusion study","volume":"16","author":"Ismail","year":"2014","journal-title":"J\u00a0Cardiovasc Magn Reson"},{"key":"10.1016\/j.ccl.2018.08.002_bib43","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1016\/j.amjcard.2009.01.294","article-title":"Relation of biomarkers and cardiac magnetic resonance imaging after marathon running","volume":"103","author":"Mousavi","year":"2009","journal-title":"Am J Cardiol"}],"container-title":["Cardiology Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733865118308610?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733865118308610?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T10:51:13Z","timestamp":1760007073000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0733865118308610"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["S0733865118308610"],"URL":"https:\/\/doi.org\/10.1016\/j.ccl.2018.08.002","relation":{},"ISSN":["0733-8651"],"issn-type":[{"type":"print","value":"0733-8651"}],"subject":[],"published":{"date-parts":[[2019,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cardiac Magnetic Resonance for Diagnosis and Risk Stratification","name":"articletitle","label":"Article Title"},{"value":"Cardiology Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ccl.2018.08.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}